MED earnings
MEDIFAST INC (MED) earnings releases and earnings dates - real-time wire coverage of every quarterly report.
Recent earnings items
- Medifast Announces First Quarter 2026 Financial ResultsMedifast (NYSE:MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the first quarter ended March 31, 2026. First Quarter 2026 Revenue of $76.0 million, with revenue per active earning coach of $5,432 Independent active earning coaches of 14,000 Net loss of $2.1 million, or $0.19 per diluted share ("EPS") Cash, Cash Equivalents, and Investment Securities of $168.9 million with no debt "We are encouraged by the continued progress we are seeing as we execute our metabolic health strategy, including a second consecutive quarter of year-over-year coach productivity growth, strong coach leadership
- Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026Medifast (NYSE:MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended March 31, 2026 on Monday, May 4, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, Nick Johnson, President, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on May 4, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or
- Medifast Announces Fourth Quarter and Full Year 2025 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Revenue of $75.1 million, with revenue per active earning coach of $4,664 Independent active earning coaches of 16,100 Net loss of $18.1 million, or $1.65 per diluted share ("EPS"), which includes the tax provision charge to establish a non-cash valuation allowance on the Company's deferred tax balance of $12.1 million (or $1.10 per diluted share) Cash, cash equivalents, and investment Securities of $167.3 million and no debt Full Year 2025 Revenue of $385
- Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025Medifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full year ended December 31, 2025 on Tuesday, February 17, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, Nick Johnson, President, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on February 17, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www
- Medifast Announces Third Quarter 2025 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. Third Quarter 2025 Revenue: $89.4 million, with revenue per active earning coach of $4,585 Active Coaches: Independent active earning OPTAVIA® coaches of 19,500 Net Loss: $2.3 million or $0.21 loss per diluted share Strong Balance Sheet: $173.5 million in cash, cash equivalents, and investment securities with no debt "We're transforming Medifast from a weight-loss company into a leader in promoting metabolic health," said Dan Chard, Chairman and Chief Executive Officer of Medifast. "Our clini
- Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025Medifast (NYSE:MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended September 30, 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on November 3, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly
- Medifast Announces Second Quarter 2025 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2025. Second Quarter 2025 Revenue: $105.6 million, with revenue per active earning coach of $4,630 Active Coaches: Independent active earning OPTAVIA coaches of 22,800 Net Income: $2.5 million or $0.22 per diluted share, which includes a gain on investment in LifeMD (NASDAQ:LFMD) common stock of $2.0 million (net of tax) Strong Balance Sheet: $162.7 million in cash, cash equivalents, and investment securities with no debt "We are working diligently to transform our business as we look to he
- Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended June 30, 2025 on Monday, August 4, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 4, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https:
- Medifast Announces First Quarter 2025 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (NASDAQ:LFMD) common stock of $0.4 million (net of tax) Loss per share of $0.07 Cash, Cash Equivalents, and Investment Securities of $164.6 million with no debt "In today's health and wellness landscape, more people than ever are seeking guidance not just for we
- Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended March 31, 2025 on Monday, April 28, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on April 28, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https:
- Medifast Announces Fourth Quarter and Full Year 2024 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Revenue of $119.0 million, with revenue per active earning coach of $4,391 Independent active earning OPTAVIA coaches of 27,100 Net income of $0.8 million (non-GAAP adjusted net income of $1.1 million) Earnings per diluted share ("EPS") of $0.07 (non-GAAP adjusted EPS of $0.10) Cash, Cash Equivalents, and Investment Securities of $162.3 million and no debt Full Year 2024 Revenue of $602.5 million Net income of $2.1 million (non-GAAP adjusted net i
- Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on February 18, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.Medif
- Medifast Announces Third Quarter 2024 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the third quarter ended September 30, 2024. Third Quarter 2024 Revenue of $140.2 million, with revenue per active earning coach of $4,672 Independent active earning OPTAVIA coaches of 30,000 Net income of $1.1 million (non-GAAP adjusted net income of $3.9 million) Income per diluted share of $0.10 (non-GAAP adjusted earnings per share ("EPS") of $0.35) Cash, Cash Equivalents, and Investment Securities of $170.0 million with no debt "Medical innovation has transformed the weight loss industry, so at Medifast we're creating a hea
- Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on November 4, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or dire
- Medifast Announces Second Quarter 2024 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Revenue of $168.6 million, with revenue per active earning Coach of $4,972 Independent active earning OPTAVIA Coaches of 33,900 Net loss of $8.2 million (non-GAAP adjusted net income of $10.1 million) Loss per diluted share of $0.75 (non-GAAP adjusted earnings per share ("EPS") of $0.92) Cash, Cash Equivalents, and Investment Securities of $163.5 million with zero debt "We are acting decisively to transform our business to position us for long-term growth, with
- Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024Medifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2024 on Monday, August 5, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 5, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at
- Medifast Announces First Quarter 2024 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2024. First Quarter 2024 Revenue of $174.7 million, with revenue per active earning coach of $4,623 Independent active earning OPTAVIA Coaches of 37,800 Net income of $8.3 million (non-GAAP adjusted net income of $7.2 million) Earnings per diluted share ("EPS") of $0.76 (non-GAAP adjusted EPS of $0.66) Cash, Cash Equivalents, and Investment Securities of $156.4 million with zero debt "Fast paced medical innovation is providing greater access to medical weight loss solutions than ever bef
- Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024Medifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on April 29, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at
- Medifast Announces Fourth Quarter and Full Year 2023 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Revenue of $191.0 million, with revenue per active earning Coach of $4,648 Independent active earning OPTAVIA Coaches of 41,100 Net income of $6.0 million (non-GAAP adjusted net income of $11.9 million) Earnings per diluted share ("EPS") of $0.55 (non-GAAP adjusted EPS of $1.09) Full Year 2023 Revenue of $1.1 billion Net income of $99.4 million (non-GAAP adjusted net income of $105.2 million) EPS of $9.10 (non-GAAP adjusted EPS of $9.64)
- Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2023Medifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2023 on Tuesday, February 20, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on February 20, 2024. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.Medif
- Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, a Virtual Primary Care Provider, and Adjusting its Capital Allocation PolicyHealth and wellness company makes $20 million capital commitment to LifeMD, enters medically supported weight loss market projected to reach up to $100 billion by 2030 Company discontinues quarterly cash dividend and intends to invest in initiatives aimed at driving customer acquisition and customer experience to reignite growth Conference call to discuss Medifast and LifeMD collaboration begins at 10 AM EST today Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today launched the first phase of its business transformation, as part of its commitment to providing comprehensive health and wellness solutions to c
- LifeMD and Medifast Partner to Offer Transformative Weight Management SolutionCollaboration will integrate LifeMD's telehealth platform and GLP-1 offering for medically qualified patients with OPTAVIA Coach-guided, healthy lifestyle solution Medifast has invested $20 million, including a $10 million payment in support of the collaboration and a $10 million purchase of LifeMD common stock Conference call to discuss LifeMD and Medifast collaboration begins at 10:00 AM EST today NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc.TM (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced a strategic alliance with Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA
- Medifast Announces Third Quarter 2023 Financial ResultsMedifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the third quarter ended September 30, 2023. Third Quarter 2023 Revenue of $235.9 million, with revenue per active earning Coach of $5,008 Independent active earning OPTAVIA Coaches of 47,100 Net income of $23.1 million Earnings per diluted share ("EPS") of $2.12 Cash, Cash Equivalents, and Investment Securities of $157.8 million and no interest-bearing debt "We are adapting our business model to adjust to the rapidly evolving health and wellness market, leveraging the power of our balance sheet and our clinically pro
- Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2023Medifast (NYSE:MED), the company behind the health and wellness community OPTAVIA®, will announce financial results for the third quarter ended September 30, 2023 on Monday, November 6, 2023, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on November 6, 2023. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/start
- Medifast Announces Second Quarter 2023 Financial ResultsBALTIMORE, Aug. 7, 2023 /PRNewswire/ -- Medifast (NYSE:MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2023. Second Quarter 2023 Revenue of $296.2 million, with revenue per active earning coach of $5,578Independent active earning OPTAVIA Coaches of 53,100Net income of $30.3 millionEarnings per diluted share ("EPS) of $2.77Cash and Cash Equivalents of $147.4 million and no interest-bearing debt"We are ahead of our Fuel for the Future plan with key initiat
- Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2023BALTIMORE, July 24, 2023 /PRNewswire/ -- Medifast (NYSE:MED), the company behind the health and wellness community OPTAVIA®, will announce financial results for the second quarter ended June 30, 2023 on Monday, August 7, 2023, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 7, 2023. The call will be broadcast live over t
- Medifast Announces First Quarter 2023 Financial ResultsBALTIMORE, May 1, 2023 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the first quarter ended March 31, 2023. First Quarter 2023 Revenue of $349.0 million, with revenue per active earning coach of $5,945Independent active earning OPTAVIA Coaches of 58,700Net income of $40.0 millionEarnings per diluted share ("EPS") of $3.67Cash and cash equivalents of $123.7 million and no interest bearing debt"We're pleased to see revenue and operating income both ahead of expecta
- Medifast to Announce Financial Results for the First Quarter Ended March 31, 2023BALTIMORE, April 17, 2023 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2023 on Monday, May 1, 2023, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on May 1, 2023. The call w
- Medifast Announces Fourth Quarter and Full Year 2022 Financial ResultsBALTIMORE, Feb. 21, 2023 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the fourth quarter ended December 31, 2022. Fourth Quarter 2022 Revenue of $337.2 million, with revenue per active earning coach of $5,538Independent active earning OPTAVIA Coaches of 60,900Net income of $26.5 million (non-GAAP adjusted net income of $40.6 million)Earnings per diluted share ("EPS") of $2.41 (non-GAAP adjusted EPS of $3.70)Full Year 2022 Highlights Revenue increased 4.8% to $1.
- Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022BALTIMORE, Feb. 7, 2023 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2022 on Tuesday, February 21, 2023, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on
- Medifast Announces Third Quarter 2022 Financial ResultsBALTIMORE, Nov. 3, 2022 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the third quarter ended September 30, 2022. Third Quarter 2022 Revenue of $390.4 million, with revenue per active earning coach of $5,897Independent active earning OPTAVIA Coaches of 66,200Net income of $36.2 million (non-GAAP adjusted net income of $36.8 million)Earnings per diluted share of $3.27 (non-GAAP adjusted EPS of $3.32)Completion of the $100 million Accelerated Share Repurchase Progr
- Medifast's OPTAVIA Program Named #1 Weight Loss Program in the U.S. by Revenue for 2021*BALTIMORE, Nov. 2, 2022 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today announced it was recognized by Euromonitor International, an independent market research firm. According to Euromonitor, Medifast's OPTAVIA Program was Named #1 Weight Loss Program in the U.S. by Revenue for 2021.* Drawn from insights based on Medifast's 40 years of scientific and clinical heritage, the OPTAVIA program was designed as a holistic approach for consumers looking for a lifestyle solution, often starting
- Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2022BALTIMORE, Oct. 20, 2022 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the third quarter ended September 30, 2022 on Thursday, November 3, 2022, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on November 3, 2
- Medifast Announces Second Quarter 2022 Financial Results and Updated OutlookBALTIMORE, Aug. 3, 2022 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights Compared to the Prior-Year PeriodRevenue increased 15.0% to $453.3 million14.9% growth in the number of independent active earning OPTAVIA Coaches to 68,000Revenue per active earning OPTAVIA Coach was $6,667 a slight increase above the prior yearNet income decreased 16.7% to $39.1 millionNon-GAAP adjusted net income decreased
- Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2022BALTIMORE, July 20, 2022 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2022 on Wednesday, August 3, 2022, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 3, 2022. Th
- Medifast, Inc. Announces First Quarter 2022 Financial ResultsBALTIMORE, May 2, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the first quarter ended March 31, 2022. First Quarter 2022 Highlights Compared to the Prior-Year Period Revenue increased 22.6% to $417.6 million21.7% growth in the number of active earning OPTAVIA Coaches to 63,900Revenue per active earning OPTAVIA Coach increased 1.3% to $6,536Net income increased 1.7% to $41.8 millionEarnings per diluted share ("EPS") of $3.59, an increase of 3.8%Annual r
- Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2022BALTIMORE, April 18, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2022 on Monday, May 2, 2022, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on May 2, 2022. The
- Medifast, Inc. Announces Fourth Quarter and Full Year 2021 Financial ResultsBALTIMORE, Feb. 23, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Highlights Compared to the Prior-Year Period Revenue increased 42.6% to $377.8 million 35.3% growth in the number of active earning OPTAVIA Coaches to 59,800 Revenue per active earning OPTAVIA Coach increased 6.6% to $6,321 Net income increased 21.5% to $34.0 million Earnings per diluted share ("EPS") of $2.91, a
- Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021BALTIMORE, Feb. 11, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2021 on Wednesday, February 23, 2022, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.
- Medifast, Inc. Announces Third Quarter 2021 Financial ResultsBALTIMORE, Nov. 4, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the third quarter ended September 30, 2021. Third Quarter 2021 Highlights Compared to the Prior-Year Period Revenue increased 52.3% to $413.4 million 44.9% growth in active earning OPTAVIA Coaches to a record level of 61,000 Revenue per active earning OPTAVIA Coach increased 7.0% to new high of $6,773 Net income increased 21.9% to $42.0 million Earnings per diluted share ("EPS") of $3.56, a
- Medifast, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2021BALTIMORE, Oct. 21, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the third quarter ended September 30, 2021 on Thursday, November 4, 2021, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on Novembe
- Medifast, Inc. Announces Second Quarter 2021 Financial ResultsBALTIMORE, Aug. 4, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the second quarter ended June 30, 2021. Second Quarter 2021 Highlights Compared to the Prior-Year Period Revenue increased 79.2% to $394.2 million 62.2% growth in active earning OPTAVIA Coaches to a record level of 59,200 Revenue per active earning OPTAVIA Coach increased 13.9% to $6,662 Net income increased 114.1% to $47.0 million Earnings per diluted share ("EPS") of $3.96, an increase of
- Medifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2021BALTIMORE, July 21, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2021 on Wednesday, August 4, 2021, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 4, 20